Search & Analyze

Popular Searches

₹965.650.72%

24 Jul, 4:01 PM

CMP₹965.65
Mkt Cap₹15.46K Cr
P/E38.80
P/B2.18
ROE14.35%
52W High₹1,250.00
52W Low₹783.75

Customise metrics bar

Stock DNA

Key Ratios

P/E Ratio

38.80

P/B Ratio

2.18

EV/EBITDA

13.14

Price/Sales

1.88

Dividend Yield (%)

0.52

EPS (TTM ₹)

25.02

Book Value (₹)

445.31

ROE (%)

14.35

ROCE (%)

13.92

ROA (%)

7.02

EBITDA Margin (%)

16.22

Net Profit Margin (%)

11.56

Debt/Equity

0.39

Current Ratio

1.62

Interest Coverage

5.08

Asset Turnover

0.61

Working Capital/Sales

5.38

Core EBITDA Growth (%)

26.92

P&L

ParticularsFY 2020-21 (Mar)FY 2021-22 (Mar)FY 2022-23 (Mar)FY 2023-24 (Mar)FY 2024-25 (Mar)
Gross Sales60985.3561301.64628176702972345
Net Sales60985.3561301.64628176702972345
Total Income61161.7361414.52632006771672913
Total Expenditure47020.7449738.32550555802160608
Operating Profit14140.9911676.28145969512305
Depreciation3489.473817.04554038193686
Exceptional Items-212.31-568-16893595
Profit Before Tax8710.766304.4727817059806
Tax2972.182174.319279781443
Profit After Tax (PAT)5738.584130.16-6497278363
EPS (₹)52.4826-3.834.8752.99
Dividend Payout %500500500500500

Balance Sheet

ParticularsFY 2020-21 (Mar)FY 2021-22 (Mar)FY 2022-23 (Mar)FY 2023-24 (Mar)FY 2024-25 (Mar)
Share Capital159.19159.19159158158
Reserves47247.5152989.81537725403662243
Shareholders Funds47414.8653185.63539935433962549
Total Debt25839.7329276.16341013414124369
Total Liabilities87633.9898295.96109292113158124990
Total Assets87633.9898295.96109292113158124990
Book Value / Share297.8368333.9133339.1887343394.943
Assets87633.9898295.96109292113158124990

Cash Flows

ParticularsFY 2020-21 (Mar)FY 2021-22 (Mar)FY 2022-23 (Mar)FY 2023-24 (Mar)FY 2024-25 (Mar)
Operating Activities17842.658375.436607971310721
Investing Activities-7390.14-3803.7-5444-60794877
Financing Activities-17093.86-325.99-1567-4325-14527
Net Cash Flow-6641.354245.74-404-6911071

JUBLPHARMA

₹965.65

+0.72%